Seth Lederman, Tonix Pharmaceuticals CEO
Tonix will test its monkeypox vaccine in Kenya next year, and no eyes on accelerated path at FDA
As monkeypox spreads across dozens of countries, one of the few biotechs publicly working on a new vaccine for the virus is gearing up to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
